HIV-1 Adaptation to Antigen Processing Results in Population-Level Immune Evasion and Affects Subtype Diversification
Summary: The recent HIV-1 vaccine failures highlight the need to better understand virus-host interactions. One key question is why CD8+ T cell responses to two HIV-Gag regions are uniquely associated with delayed disease progression only in patients expressing a few rare HLA class I variants when t...
Main Authors: | , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2014-04-01
|
Series: | Cell Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2211124714002095 |
id |
doaj-70c00bdc9a134a478cc0c679e6af3abb |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Stefan Tenzer Hayley Crawford Phillip Pymm Robert Gifford Vattipally B. Sreenu Mirjana Weimershaus Tulio de Oliveira Anne Burgevin Jan Gerstoft Nadja Akkad Daniel Lunn Lars Fugger John Bell Hansjörg Schild Peter van Endert Astrid K.N. Iversen |
spellingShingle |
Stefan Tenzer Hayley Crawford Phillip Pymm Robert Gifford Vattipally B. Sreenu Mirjana Weimershaus Tulio de Oliveira Anne Burgevin Jan Gerstoft Nadja Akkad Daniel Lunn Lars Fugger John Bell Hansjörg Schild Peter van Endert Astrid K.N. Iversen HIV-1 Adaptation to Antigen Processing Results in Population-Level Immune Evasion and Affects Subtype Diversification Cell Reports |
author_facet |
Stefan Tenzer Hayley Crawford Phillip Pymm Robert Gifford Vattipally B. Sreenu Mirjana Weimershaus Tulio de Oliveira Anne Burgevin Jan Gerstoft Nadja Akkad Daniel Lunn Lars Fugger John Bell Hansjörg Schild Peter van Endert Astrid K.N. Iversen |
author_sort |
Stefan Tenzer |
title |
HIV-1 Adaptation to Antigen Processing Results in Population-Level Immune Evasion and Affects Subtype Diversification |
title_short |
HIV-1 Adaptation to Antigen Processing Results in Population-Level Immune Evasion and Affects Subtype Diversification |
title_full |
HIV-1 Adaptation to Antigen Processing Results in Population-Level Immune Evasion and Affects Subtype Diversification |
title_fullStr |
HIV-1 Adaptation to Antigen Processing Results in Population-Level Immune Evasion and Affects Subtype Diversification |
title_full_unstemmed |
HIV-1 Adaptation to Antigen Processing Results in Population-Level Immune Evasion and Affects Subtype Diversification |
title_sort |
hiv-1 adaptation to antigen processing results in population-level immune evasion and affects subtype diversification |
publisher |
Elsevier |
series |
Cell Reports |
issn |
2211-1247 |
publishDate |
2014-04-01 |
description |
Summary: The recent HIV-1 vaccine failures highlight the need to better understand virus-host interactions. One key question is why CD8+ T cell responses to two HIV-Gag regions are uniquely associated with delayed disease progression only in patients expressing a few rare HLA class I variants when these regions encode epitopes presented by ∼30 more common HLA variants. By combining epitope processing and computational analyses of the two HIV subtypes responsible for ∼60% of worldwide infections, we identified a hitherto unrecognized adaptation to the antigen-processing machinery through substitutions at subtype-specific motifs. Multiple HLA variants presenting epitopes situated next to a given subtype-specific motif drive selection at this subtype-specific position, and epitope abundances correlate inversely with the HLA frequency distribution in affected populations. This adaptation reflects the sum of intrapatient adaptations, is predictable, facilitates viral subtype diversification, and increases global HIV diversity. Because low epitope abundance is associated with infrequent and weak T cell responses, this most likely results in both population-level immune evasion and inadequate responses in most people vaccinated with natural HIV-1 sequence constructs. Our results suggest that artificial sequence modifications at subtype-specific positions in vitro could refocus and reverse the poor immunogenicity of HIV proteins. : CD8+ T cell responses against HIV-1 effectively delay disease progression in a minority of patients with relatively rare HLA variants but are ineffective in most. Here, Tenzer et al. identify fundamental HIV-1 adaptation to the conserved human antigen-processing machinery that feeds epitopes to HLA. This adaptation occurs at subtype-specific motifs, facilitates subtype diversification, is predictable, and results in CD8 epitope abundances that correlate inversely with the HLA allele frequencies in affected populations. Thus, HIV vaccine immunogenicity might be increased by unnatural substitutions at subtype-specific motifs. |
url |
http://www.sciencedirect.com/science/article/pii/S2211124714002095 |
work_keys_str_mv |
AT stefantenzer hiv1adaptationtoantigenprocessingresultsinpopulationlevelimmuneevasionandaffectssubtypediversification AT hayleycrawford hiv1adaptationtoantigenprocessingresultsinpopulationlevelimmuneevasionandaffectssubtypediversification AT phillippymm hiv1adaptationtoantigenprocessingresultsinpopulationlevelimmuneevasionandaffectssubtypediversification AT robertgifford hiv1adaptationtoantigenprocessingresultsinpopulationlevelimmuneevasionandaffectssubtypediversification AT vattipallybsreenu hiv1adaptationtoantigenprocessingresultsinpopulationlevelimmuneevasionandaffectssubtypediversification AT mirjanaweimershaus hiv1adaptationtoantigenprocessingresultsinpopulationlevelimmuneevasionandaffectssubtypediversification AT tuliodeoliveira hiv1adaptationtoantigenprocessingresultsinpopulationlevelimmuneevasionandaffectssubtypediversification AT anneburgevin hiv1adaptationtoantigenprocessingresultsinpopulationlevelimmuneevasionandaffectssubtypediversification AT jangerstoft hiv1adaptationtoantigenprocessingresultsinpopulationlevelimmuneevasionandaffectssubtypediversification AT nadjaakkad hiv1adaptationtoantigenprocessingresultsinpopulationlevelimmuneevasionandaffectssubtypediversification AT daniellunn hiv1adaptationtoantigenprocessingresultsinpopulationlevelimmuneevasionandaffectssubtypediversification AT larsfugger hiv1adaptationtoantigenprocessingresultsinpopulationlevelimmuneevasionandaffectssubtypediversification AT johnbell hiv1adaptationtoantigenprocessingresultsinpopulationlevelimmuneevasionandaffectssubtypediversification AT hansjorgschild hiv1adaptationtoantigenprocessingresultsinpopulationlevelimmuneevasionandaffectssubtypediversification AT petervanendert hiv1adaptationtoantigenprocessingresultsinpopulationlevelimmuneevasionandaffectssubtypediversification AT astridkniversen hiv1adaptationtoantigenprocessingresultsinpopulationlevelimmuneevasionandaffectssubtypediversification |
_version_ |
1724947072363266048 |
spelling |
doaj-70c00bdc9a134a478cc0c679e6af3abb2020-11-25T02:03:36ZengElsevierCell Reports2211-12472014-04-0172448463HIV-1 Adaptation to Antigen Processing Results in Population-Level Immune Evasion and Affects Subtype DiversificationStefan Tenzer0Hayley Crawford1Phillip Pymm2Robert Gifford3Vattipally B. Sreenu4Mirjana Weimershaus5Tulio de Oliveira6Anne Burgevin7Jan Gerstoft8Nadja Akkad9Daniel Lunn10Lars Fugger11John Bell12Hansjörg Schild13Peter van Endert14Astrid K.N. Iversen15Institute of Immunology, University Medical Center of the Johannes-Gutenberg University of Mainz, Langenbeckstrasse 1, 55131 Mainz, GermanyMedical Research Council Human Immunology Unit, Weatherall Institute of Molecular Medicine, Oxford University, John Radcliffe Hospital, Headley Way, Oxford OX3 9DS, UK; Division of Clinical Neurology, Nuffield Department of Clinical Neurosciences, Weatherall Institute of Molecular Medicine, Oxford University, John Radcliffe Hospital, Headley Way, Oxford OX3 9DS, UKMedical Research Council Human Immunology Unit, Weatherall Institute of Molecular Medicine, Oxford University, John Radcliffe Hospital, Headley Way, Oxford OX3 9DS, UK; Division of Clinical Neurology, Nuffield Department of Clinical Neurosciences, Weatherall Institute of Molecular Medicine, Oxford University, John Radcliffe Hospital, Headley Way, Oxford OX3 9DS, UKAaron Diamond AIDS Research Center, 455 First Avenue, New York, NY 10016, USAMedical Research Council Human Immunology Unit, Weatherall Institute of Molecular Medicine, Oxford University, John Radcliffe Hospital, Headley Way, Oxford OX3 9DS, UKInstitut National de la Santé et de la Recherche Médicale, Unité 1151, Centre National de la Recherche Scientifique, UMR8253, Université Paris Descartes, Sorbonne Paris Cité, Hôpital Necker, 149 rue de Sèvres, 75015 Paris, FranceAfrica Centre for Health and Population Studies, School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, KwaZulu-Natal 3935, South Africa; Research Department of Infection, University College London, Cruciform Building, 90 Gower Street, London WC1E 6BT, UKInstitut National de la Santé et de la Recherche Médicale, Unité 1151, Centre National de la Recherche Scientifique, UMR8253, Université Paris Descartes, Sorbonne Paris Cité, Hôpital Necker, 149 rue de Sèvres, 75015 Paris, FranceDepartment of Infectious Diseases, Rigshospitalet, The National University Hospital, Blegdamsvej 9, 2100 Kbh Ø Copenhagen, DenmarkInstitute of Immunology, University Medical Center of the Johannes-Gutenberg University of Mainz, Langenbeckstrasse 1, 55131 Mainz, GermanyDepartment of Statistics, University of Oxford, 1 South Parks Road, Oxford OX1 3TG, UKMedical Research Council Human Immunology Unit, Weatherall Institute of Molecular Medicine, Oxford University, John Radcliffe Hospital, Headley Way, Oxford OX3 9DS, UK; Division of Clinical Neurology, Nuffield Department of Clinical Neurosciences, Weatherall Institute of Molecular Medicine, Oxford University, John Radcliffe Hospital, Headley Way, Oxford OX3 9DS, UKOffice of the Regius Professor of Medicine, The Richard Doll Building, University of Oxford, Old Road Campus, Roosevelt Drive 1, Oxford OX3 7LF, UKInstitute of Immunology, University Medical Center of the Johannes-Gutenberg University of Mainz, Langenbeckstrasse 1, 55131 Mainz, GermanyInstitut National de la Santé et de la Recherche Médicale, Unité 1151, Centre National de la Recherche Scientifique, UMR8253, Université Paris Descartes, Sorbonne Paris Cité, Hôpital Necker, 149 rue de Sèvres, 75015 Paris, FranceMedical Research Council Human Immunology Unit, Weatherall Institute of Molecular Medicine, Oxford University, John Radcliffe Hospital, Headley Way, Oxford OX3 9DS, UK; Division of Clinical Neurology, Nuffield Department of Clinical Neurosciences, Weatherall Institute of Molecular Medicine, Oxford University, John Radcliffe Hospital, Headley Way, Oxford OX3 9DS, UK; Corresponding authorSummary: The recent HIV-1 vaccine failures highlight the need to better understand virus-host interactions. One key question is why CD8+ T cell responses to two HIV-Gag regions are uniquely associated with delayed disease progression only in patients expressing a few rare HLA class I variants when these regions encode epitopes presented by ∼30 more common HLA variants. By combining epitope processing and computational analyses of the two HIV subtypes responsible for ∼60% of worldwide infections, we identified a hitherto unrecognized adaptation to the antigen-processing machinery through substitutions at subtype-specific motifs. Multiple HLA variants presenting epitopes situated next to a given subtype-specific motif drive selection at this subtype-specific position, and epitope abundances correlate inversely with the HLA frequency distribution in affected populations. This adaptation reflects the sum of intrapatient adaptations, is predictable, facilitates viral subtype diversification, and increases global HIV diversity. Because low epitope abundance is associated with infrequent and weak T cell responses, this most likely results in both population-level immune evasion and inadequate responses in most people vaccinated with natural HIV-1 sequence constructs. Our results suggest that artificial sequence modifications at subtype-specific positions in vitro could refocus and reverse the poor immunogenicity of HIV proteins. : CD8+ T cell responses against HIV-1 effectively delay disease progression in a minority of patients with relatively rare HLA variants but are ineffective in most. Here, Tenzer et al. identify fundamental HIV-1 adaptation to the conserved human antigen-processing machinery that feeds epitopes to HLA. This adaptation occurs at subtype-specific motifs, facilitates subtype diversification, is predictable, and results in CD8 epitope abundances that correlate inversely with the HLA allele frequencies in affected populations. Thus, HIV vaccine immunogenicity might be increased by unnatural substitutions at subtype-specific motifs.http://www.sciencedirect.com/science/article/pii/S2211124714002095 |